Search research articles
Contact Us
Filters
Showing results (81-90 of 126) with videos related to
Page
of 13
Sort By:
Rheumatology (Oxford, England)
|
June 5, 2007
Cost effectiveness of adalimumab for the treatment of ankylosing spondylitis in the United Kingdom
M F Botteman, J W Hay, M P Luo, et al.
Advances in Therapy
|
November 19, 2021
An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach
Marjanne A Piena, Sonja Kroep, Claire Simons, et al.
Current Medical Research and Opinion
|
May 1, 2010
Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections
J Floris S Logman, Jennifer Stephens, Bart Heeg, et al.
Health Economics
|
May 1, 1997
Modelling in economic evaluation: an unavoidable fact of life
M J Buxton, M F Drummond, B A Van Hout, et al.
Pharmacoeconomics
|
January 19, 2006
Modelling the treated course of schizophrenia: development of a discrete event simulation model
Bart Heeg, Erik Buskens, Martin Knapp, et al.
Infection Control and Hospital Epidemiology
|
December 1, 1996
Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery
M F VandenBergh, J A Kluytmans, B A van Hout, et al.
Vox Sanguinis
|
February 21, 2009
Monitoring viral incidence rates: tools for the implementation of European Union regulations
M P Janssen, E A Cator, C L van der Poel, et al.
Vox Sanguinis
|
August 24, 2010
Survival after transfusion in the Netherlands
B A Borkent-Raven, M P Janssen, C L van der Poel, et al.
European Journal of Immunology
|
August 11, 2015
Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists
Martin Kreutz, Ghaith Bakdash, Yusuf Dolen, et al.
Vox Sanguinis
|
March 6, 2010
The PROTON study: profiles of blood product transfusion recipients in the Netherlands
B A Borkent-Raven, M P Janssen, C L van der Poel, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 126) with videos related to
Sort By:
Page
of 13
Rheumatology (Oxford, England)
|
June 5, 2007
Cost effectiveness of adalimumab for the treatment of ankylosing spondylitis in the United Kingdom
M F Botteman, J W Hay, M P Luo, et al.
Advances in Therapy
|
November 19, 2021
An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach
Marjanne A Piena, Sonja Kroep, Claire Simons, et al.
Current Medical Research and Opinion
|
May 1, 2010
Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections
J Floris S Logman, Jennifer Stephens, Bart Heeg, et al.
Health Economics
|
May 1, 1997
Modelling in economic evaluation: an unavoidable fact of life
M J Buxton, M F Drummond, B A Van Hout, et al.
Pharmacoeconomics
|
January 19, 2006
Modelling the treated course of schizophrenia: development of a discrete event simulation model
Bart Heeg, Erik Buskens, Martin Knapp, et al.
Infection Control and Hospital Epidemiology
|
December 1, 1996
Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery
M F VandenBergh, J A Kluytmans, B A van Hout, et al.
Vox Sanguinis
|
February 21, 2009
Monitoring viral incidence rates: tools for the implementation of European Union regulations
M P Janssen, E A Cator, C L van der Poel, et al.
Vox Sanguinis
|
August 24, 2010
Survival after transfusion in the Netherlands
B A Borkent-Raven, M P Janssen, C L van der Poel, et al.
European Journal of Immunology
|
August 11, 2015
Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists
Martin Kreutz, Ghaith Bakdash, Yusuf Dolen, et al.
Vox Sanguinis
|
March 6, 2010
The PROTON study: profiles of blood product transfusion recipients in the Netherlands
B A Borkent-Raven, M P Janssen, C L van der Poel, et al.
Page
of 13